Discovery of Salt Gully Virus in Australian Bats Enhances Preparedness Against Emerging Infectious Diseases

Scientists at CSIRO have discovered the Salt Gully virus in Australian bats, enhancing disease preparedness and understanding of henipaviruses potentially impacting human and animal health.
Researchers at CSIRO, Australia's premier scientific organization, have identified a novel virus in local flying fox populations, marking a significant advancement in the country's ability to anticipate and counter emerging infectious threats. The newly detected Salt Gully virus is a type of henipavirus, related to others like Hendra and Nipah viruses, which are known to cause severe diseases in animals and humans.
The Salt Gully virus was found in urine samples from bats in Queensland and was successfully isolated in CSIRO's high-containment laboratory, the Australian Centre for Disease Preparedness. Its detection in samples dating back to 2011 indicates the virus has been circulating in native bat populations for over ten years without causing apparent illness.
This discovery provides valuable insights into the diversity of henipaviruses and their potential risks. Although Salt Gully virus shares its family with Hendra, which has led to fatal outbreaks, current evidence suggests it does not rely on the same cell receptors, possibly reducing its immediate threat. However, understanding this virus lays the groundwork for developing diagnostic tools that can detect possible spillovers in the future.
Jennifer Barr, a senior scientist involved in the research, emphasized that the virus's presence in bats doesn't pose an immediate public health threat. "We've detected Salt Gully virus in bat populations without any evidence of disease in animals or humans so far. This finding helps us understand the full scope of henipavirus diversity and guides future research into their potential to cause outbreaks."
Enhanced knowledge of Salt Gully virus underscores the importance of ongoing surveillance and research. It also confirms that Australia’s current Hendra vaccination efforts for horses remain effective and are not compromised by this new virus.
The Australian Centre for Disease Preparedness continues to play a critical role in biosecurity, allowing scientists to study zoonotic diseases safely and securely. This research not only deepens understanding of wild-origin viruses but also improves preparedness for any future spillover events that could impact public and animal health.
For further details, this study is published in Emerging Infectious Diseases. The findings highlight the importance of proactive research in identifying and characterizing wildlife viruses to mitigate future health risks.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Breakthrough in Bladder Cancer Detection: New Biomarker Identified for Early Diagnosis in Humans and Dogs
Research unveils a novel biomarker, α5β1 integrin, for early detection of bladder cancer in both humans and dogs, paving the way for improved targeted therapies and diagnosis.
Understanding the Brain-Eating Amoeba and Its Deadly Risks for Swimmers
Learn about Naegleria fowleri, a deadly amoeba found in warm freshwater lakes, its risks, symptoms, and how to stay safe while enjoying natural waters this summer.
Innovative Approach: Nuclear Speckle Rejuvenation as a Potential Treatment for Neurodegenerative Diseases
New research highlights nuclear speckle rejuvenation as a promising novel strategy for treating neurodegenerative diseases like Alzheimer's and Parkinson's, offering hope for future therapies.
New Immunotherapy Approved in England for Severe Birch Pollen Allergies in Hay Fever Patients
A new immunotherapy treatment for severe birch pollen allergies has been approved in England, offering hope for better management of hay fever symptoms by training the immune system to build tolerance.



